Literature DB >> 29490946

TRPM2 Mediates Neutrophil Killing of Disseminated Tumor Cells.

Maya Gershkovitz1, Yaki Caspi2, Tanya Fainsod-Levi1, Ben Katz2, Janna Michaeli3, Saleh Khawaled4, Shaya Lev2, Lola Polyansky1, Merav E Shaul3, Ronit V Sionov1, Leonor Cohen-Daniel4, Rami I Aqeilan4, Yoav D Shaul5, Yasuo Mori6, Rotem Karni5, Zvi G Fridlender3, Alexander M Binshtok2, Zvi Granot7.   

Abstract

Neutrophils play a critical role in cancer, with both protumor and antitumor neutrophil subpopulations reported. The antitumor neutrophil subpopulation has the capacity to kill tumor cells and limit metastatic spread, yet not all tumor cells are equally susceptible to neutrophil cytotoxicity. Because cells that evade neutrophils have greater chances of forming metastases, we explored the mechanism neutrophils use to kill tumor cells. Neutrophil cytotoxicity was previously shown to be mediated by secretion of H2O2 We report here that neutrophil cytotoxicity is Ca2+ dependent and is mediated by TRPM2, a ubiquitously expressed H2O2-dependent Ca2+ channel. Perturbing TRPM2 expression limited tumor cell proliferation, leading to attenuated tumor growth. Concomitantly, cells expressing reduced levels of TRPM2 were protected from neutrophil cytotoxicity and seeded more efficiently in the premetastatic lung.Significance: These findings identify the mechanism utilized by neutrophils to kill disseminated tumor cells and to limit metastatic spread. Cancer Res; 78(10); 2680-90. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29490946     DOI: 10.1158/0008-5472.CAN-17-3614

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Neutrophil Cathepsin G and Tumor Cell RAGE Facilitate Neutrophil Anti-Tumor Cytotoxicity.

Authors:  Ronit Vogt Sionov; Tanya Fainsod-Levi; Tamir Zelter; Lola Polyansky; Christine T Pham; Zvi Granot
Journal:  Oncoimmunology       Date:  2019-06-11       Impact factor: 8.110

Review 2.  TRPM2 in Cancer.

Authors:  Barbara A Miller
Journal:  Cell Calcium       Date:  2019-03-06       Impact factor: 6.817

Review 3.  Neutrophil plasticity in the tumor microenvironment.

Authors:  Morgan A Giese; Laurel E Hind; Anna Huttenlocher
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

Review 4.  Improved mouse models and advanced genetic and genomic technologies for the study of neutrophils.

Authors:  Vishnu Hosur; Daniel A Skelly; Christopher Francis; Benjamin E Low; Vivek Kohar; Lisa M Burzenski; Mansoor M Amiji; Leonard D Shultz; Michael V Wiles
Journal:  Drug Discov Today       Date:  2020-05-05       Impact factor: 7.851

Review 5.  Neutrophil Diversity in Health and Disease.

Authors:  Carlos Silvestre-Roig; Zvi G Fridlender; Michael Glogauer; Patrizia Scapini
Journal:  Trends Immunol       Date:  2019-05-31       Impact factor: 16.687

Review 6.  The Calcium-Signaling Toolkit in Cancer: Remodeling and Targeting.

Authors:  Sarah J Roberts-Thomson; Silke B Chalmers; Gregory R Monteith
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

Review 7.  The complexity of neutrophils in health and disease: Focus on cancer.

Authors:  Silvia Carnevale; Somayehsadat Ghasemi; Anna Rigatelli; Sebastien Jaillon
Journal:  Semin Immunol       Date:  2020-09-18       Impact factor: 11.130

Review 8.  Neutrophil diversity and plasticity in tumour progression and therapy.

Authors:  Sebastien Jaillon; Andrea Ponzetta; Diletta Di Mitri; Angela Santoni; Raffaella Bonecchi; Alberto Mantovani
Journal:  Nat Rev Cancer       Date:  2020-07-21       Impact factor: 60.716

Review 9.  Tumor microenvironment as a therapeutic target in cancer.

Authors:  Yi Xiao; Dihua Yu
Journal:  Pharmacol Ther       Date:  2020-11-28       Impact factor: 12.310

Review 10.  Neutrophils in cancer: heterogeneous and multifaceted.

Authors:  Catherine C Hedrick; Ilaria Malanchi
Journal:  Nat Rev Immunol       Date:  2021-07-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.